Early petechiae in leukemia may be treated with platelet boosting, transfusion of single platelets of the same blood group, and improvement of coagulation.
Early petechiae in leukemia patients are caused by lower platelet count or abnormal coagulation function. Leukemia cells in leukemia patients can inhibit the normal hematopoiesis of bone marrow and cause the production of platelets, red blood cells and normal white blood cells, and the chemotherapy drugs used for treating leukemia can lead to bone marrow suppression and reduce the production of platelets.
When the platelet count decreases, the patient’s skin mucosa may show bleeding manifestations such as petechiae. The key to treating early petechiae in leukemia is to raise the platelet count, which can be done by subcutaneous injection of recombinant human thrombopoietin; oral administration of drugs such as Lycopodium tablets and aminopeptide tablets; and transfusion of single-collected platelets of the same blood type.
Acute promyelocytic leukemia in leukemia is easily complicated by disseminated intravascular coagulation in the early stage, resulting in severe coagulation dysfunction, which leads to the occurrence of petechiae. According to the patient’s condition, intravenous infusion of fresh frozen plasma or cold precipitation is needed to correct the coagulation dysfunction, and at the same time, all-trans retinoic acid, arsenic trioxide, or cotrimoxazole tablets are given to double-induce differentiation to treat the primary disease.
It is recommended that when early petechiae occur in leukocyte patients, the hematologist should formulate a treatment plan based on the patient’s specific condition, and avoid strenuous activities and collisions, and keep the bowels unobstructed in order to prevent the occurrence of more serious bleeding complications. Medications need to be used under medical supervision.